James V Pellicane Jr. MD FACS
Breast
Director of Breast Oncology, Bon Secours VA Breast Center, Bon Secours Cancer Institute, Richmond VA
Join to View Full Profile
5875 Bremo RdSte G-11Richmond, VA 23226
Phone+1 804-594-3130
Fax+1 804-423-6517
Dr. Pellicane is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Virginia Commonwealth University Health SystemResidency, Surgery, 1991 - 1994- Virginia Commonwealth University Health SystemResidency, Urology, 1990 - 1991
- Virginia Commonwealth University Health SystemResidency, Surgery, 1988 - 1990
University of Pittsburgh School of MedicineClass of 1988
Certifications & Licensure
VA State Medical License 1990 - 2026
American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACS) American College of Surgeons
Clinical Trials
- NBRST: Prospective Neo-adjuvant REGISTRY Trial Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- ASO Visual Abstract: The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Cons...Chirag Shah, Pat Whitworth, Frank A Vicini, Steven Narod, Naamit Gerber
Annals of Surgical Oncology. 2024-09-01 - 6 citationsThe Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Up...Chirag Shah, Pat Whitworth, Frank A Vicini, Steven Narod, Naamit Gerber
Annals of Surgical Oncology. 2024-09-01 - 1 citationsCombined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome i...James V Pellicane, Peter D Beitsch, David T Rock, Raye J Budway, Carrie L Dul
Surgical Oncology. 2022-12-01
Press Mentions
Going for the Moon ShotApril 24th, 2023- Top Docs 2021April 26th, 2021
- Data Presented at the Miami Breast Cancer Conference Show MammaPrintMarch 4th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
